ABIOMED, Inc. (ABMD)

(NasdaqGS: ABMD)

SUMMARY

 
 

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In ABIOMED, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at ABIOMED, Inc. (“Abiomed” or the “Company”) (NasdaqGS: ABMD).

The investigation focuses on whether the Company and its executives violated federal securities laws by misrepresenting and mislabeling Abiomed’s Impella 2.5 heart pump.

Abiomed announced on November 1, 2012 that the Washington, D.C. Attorney’s Office was conducting an investigation focused on the marketing and labeling of the Company’s Impella 2.5 product.  On October 31, 2012, Abiomed accepted service of a Health Insurance Portability and Accountability Act administrative subpoena related to this investigation.  The subpoena seeks documents related to the Impella 2.5 and focuses primarily on marketing and labeling issues.

Abiomed’s announcement follows a June 2011 warning letter from the United States Food and Drug Administration accusing the Company of making unsubstantiated and unauthorized efficacy claims about the Impella 2.5 system in its marketing materials.

Following the Company’s announcement on November 1, 2012, Abiomed stock plunged from a $19.82 closing price on October 31, 2012 to close at $13.61 on November 1, 2012 – losing almost a third of its value.

Take Action

If you purchased Abiomed stock or options and would like to discuss your legal rights, contact us by calling Richard Gonnello or Francis McConville toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com or fmcconville@faruqilaw.com.  Faruqi & Faruqi, LLP also encourages anyone with information regarding Abiomed’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

 
 

Request Information

 
  Please tell us about yourself by completing the form and we will provide you with additional
information on how to join the Class Action at no cost to you. If you want to be a Lead Plaintiff or join
this action now, please click HERE.
Case:ABIOMED, Inc. (ABMD)
 
 
*Security code:
 
   
 
 

Contact Counsel

Richard W. Gonnello

Faruqi & Faruqi, LLP
369 Lexington Avenue 10th Floor
New York, NY 10017
Tel: (212) 983-9330
Email:  rgonnello@faruqilaw.com

Send Information

If you have information regarding this case that you would
like to make available, please click here to contact us
about our investigation